(Q35152226)

6 August 2017

0 references

1 reference

title

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis (English)

1 reference

6 August 2017

0 references

1 reference

1 reference

neoadjuvant chemotherapy

1 reference

1 reference

Advanced Bladder Cancer Meta-analysis Collaboration

series ordinal

1

1 reference

PubMed ID

12801735

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

6 August 2017

1 reference

6 August 2017

361

1 reference

6 August 2017

1927-1934

1 reference

6 August 2017

9373

1 reference

6 August 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Cis-diamminedichloroplatinum (II) in locally advanced and metastatic urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Cis-diamminedichloroplatinum (DDP) as initial treatment of invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Neoadjuvant chemotherapy with cisplatin and methotrexate in patients with muscle-invasive bladder tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Neo-adjuvant (Pre-emptive) Cisplatin Therapy in Invasive Transitional Cell Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced Bladder Cancer Overview Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

1 reference

7 January 2021

Systematic reviews using individual patient data: a map for the minefields?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Neoadjuvant therapy for locally invasive bladder cancer: results of randomized trials in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

Adjuvant chemotherapy in T3 carcinoma of the bladder. A prospective trial: preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2913580-5

7 January 2021

10.1016/S0140-6736(03)13580-5

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12801735